SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India
Journal of Microbiology and Biotechnology · 2026
DOI: 10.4014/jmb.2605.05029 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Microbiology and Biotechnology, 2026. Verfasst von Sanika Limaye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biosciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India. Hauptthemen laut MEDLINE: Biomarkers, Irritable Bowel Syndrome, Fatty Acids, Volatile. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biosciences and Technology, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
- Department of Public Health, Dr. Vishwanath Karad MIT World Peace University, Pune, India.
Zitieren
APA
Limaye, S., Bhide, P., Kale, A., & Bokey, N. (2026). SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India. Journal of Microbiology and Biotechnology. https://doi.org/10.4014/jmb.2605.05029
Vancouver
Limaye S, Bhide P, Kale A, Bokey N. SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India. Journal of Microbiology and Biotechnology. 2026. doi:10.4014/jmb.2605.05029
BibTeX
@article{Limaye2026,
author = {Limaye, Sanika and Bhide, Prajkta and Kale, Anup and Bokey, Neha},
title = {SCFA Alterations in IBS Subtypes: Systematic Evidence and Future Prospects for Biomarker-Based Diagnosis in India},
journal = {Journal of Microbiology and Biotechnology},
year = {2026},
doi = {10.4014/jmb.2605.05029}
}
EUVIMED